Sanofi-Aventis has bolstered its emerging markets team with the appointment of four senior managers. They are Patrick Aghanian, Thomas Kelly, …
2010 saw a harsh new economic reality dominate decisions in the US and Europe, but pharma seized on opportunities in …
Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …
China will replace the US as the number one ‘powerhouse of innovation’ within the next ten years according to a …
GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …

The march of foreign pharma companies into China is to continue with Eli Lilly and Co’s opening of a diabetes …
Swiss-based Nycomed has acquired a majority stake in Guangdong Techpool biopharma in China, extending its presence in the top tier …
As industry pressure to conduct successful global clinical trials on time and on budget continue, tapping emerging global markets will …
The global pharma market is forecast to reach $880 billion by 2011, driven by growth in the Chinese market. Analysts …
There has been progress in China on the development of drug master files for pharmaceutical ingredients and components, highlighting once …
Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …
Bayer is partnering with the People’s Liberation Army General Hospital in Beijing on research into women’s healthcare. The People’s Liberation …
Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …
IMS Health has added 10 more countries to its list of ‘pharmerging markets’ which represent the future of pharma industry …
WuXi Pharmatech, one of China’s leading contract research organisations, has been motoring ahead in recent quarters while its western counterparts …